by Plus Therapeutics | Oct 13, 2025 | LM
Did you know that as many as 5% to 20% of people with advanced breast cancer may eventually develop leptomeningeal metastases (LM) — also known as leptomeningeal disease (LMD)? LM occurs when cancer cells spread to the membranes (meninges) that surround the brain and...
by Plus Therapeutics | Oct 13, 2025 | LM
Today marks Metastatic Breast Cancer Awareness Day — a time to honor those living with stage IV breast cancer, remember those we’ve lost, and reaffirm our shared commitment to ending the disease. While significant progress has been made in early-stage breast cancer...
by Plus Therapeutics | Oct 7, 2025 | LM
Leptomeningeal metastases (LM) occur when cancer spreads to the delicate membranes surrounding the brain and spinal cord — a complication that affects thousands of patients each year. Because LM often develops silently and can be difficult to detect through standard...
by Plus Therapeutics | Oct 6, 2025 | Uncategorized
This past weekend, Plus Therapeutics’ Andrew Sims and Conroy Campbell proudly participated in the Winship 5K, supporting the Winship Cancer Institute of Emory University and its mission to advance lifesaving cancer research. The annual Winship 5K unites cancer...
by Plus Therapeutics | Sep 22, 2025 | LM
Plus Therapeutics, Inc. (Nasdaq: PSTV) today announced it has received an additional $1.9 million advance payment from the Cancer Prevention and Research Institute of Texas (CPRIT) — the second-largest public cancer research funder globally. This latest payment is...
Recent Comments